Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular membrane, composed of a phospholipid bilayer with embedded proteins and cholesterol, is a major site of oxidative damage. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) can attack membrane lipids and proteins, leading to lipid peroxidation, protein oxidation, increased permeability, and ultimately, cell death. This process is implicated in a wide range of diseases and biological processes, including aging, cancer, and neurodegeneration. While cells possess antioxidant defense mechanisms, severe or prolonged oxidative stress can overwhelm these systems, leading to irreversible damage.
Not applicable (this is a structural entity undergoing damage, not a drug target in the traditional sense). Drugs may indirectly affect membrane oxidation via modulation of ROS production or antioxidant defenses.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular Membrane (Oxidative Damage).